30 ml/ min) и на пациенти с бъбречно заболяване в крайна фаза (ESRD) налагащо хемодиализа.
A single 240 mg dose of aprepitant was administered to patients with severe renal impairment (CrCl < 30 ml/ min) and to patients with end stage renal disease (ESRD) requiring haemodialysis.